Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review

被引：21
|
作者：
King, Jordan B. [1 ]
Bress, Adam P. [1 ,2 ]
Reese, Austin D. [1 ]
Munger, Mark A. [1 ,3 ]
机构：
[1] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA
[2] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA
来源：
PHARMACOTHERAPY | 2015年 / 35卷 / 09期
关键词：
heart failure with reduced ejection fraction; systolic heart failure; neprilysin inhibition; therapeutic review; pharmacotherapy; CONVERTING-ENZYME-INHIBITORS; NEUTRAL ENDOPEPTIDASE INHIBITOR; VENTRICULAR SYSTOLIC FUNCTION; NATRIURETIC PEPTIDES; RANDOMIZED TRIAL; MORBIDITY; MORTALITY; LCZ696; CANDESARTAN; ENALAPRIL;
D O I：
10.1002/phar.1629
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
There has been a 10-year hiatus in the approval of a new pharmacotherapy for patients with chronic heart failure with a reduced ejection fraction (HFrEF). Combining an angiotensin receptor blocker, valsartan, with sacubitril, an inhibitor of neprilysin, results in increasing levels of natriuretic peptides that counterbalance high circulating levels of neurohormones in HFrEF. This has resulted in the development of a new agent, LCZ696. A comprehensive overview of LCZ696, its pharmacology, its role in the pathophysiology of HFrEF, completed and future clinical trial information, specific critical issues, and the place of LCZ696 in HFrEF therapy are presented.
引用
收藏
页码：823 / 837
页数：15
相关论文
共 50 条
  • [1] Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction A Paradigm for All?
    Konstam, Marvin A.
    JACC-HEART FAILURE, 2016, 4 (10) : 823 - 825
  • [2] Efficacy of angiotensin–neprilysin inhibition versus enalapril in patient with heart failure with a reduced ejection fraction
    Laura Ferrari
    Simona Sada
    Internal and Emergency Medicine, 2015, 10 : 369 - 371
  • [3] Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
    Gupta, Kartik
    Bajaj, Navkaranbir S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1180 - 1181
  • [4] Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
    Solomon, S. D.
    McMurray, J. J. V.
    Anand, I. S.
    Ge, J.
    Lam, C. S. P.
    Maggioni, A. P.
    Martinez, F.
    Packer, M.
    Pfeffer, M. A.
    Pieske, B.
    Redfield, M. M.
    Rouleau, J. L.
    van Veldhuisen, D. J.
    Zannad, F.
    Zile, M. R.
    Desai, A. S.
    Claggett, B.
    Jhund, P. S.
    Boytsov, S. A.
    Comin-Colet, J.
    Cleland, J.
    Dungen, H. -D.
    Goncalvesova, E.
    Katova, T.
    Kerr Saraiva, J. F.
    Lelonek, M.
    Merkely, B.
    Senni, M.
    Shah, S. J.
    Zhou, J.
    Rizkala, A. R.
    Gong, J.
    Shi, V. C.
    Lefkowitz, M. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1609 - 1620
  • [5] Effects of angiotensin receptor neprilysin inhibition on pulmonary arterial stiffness in heart failure with reduced ejection fraction
    Mustafa Yenerçağ
    Uğur Arslan
    Seçkin Dereli
    Metin Çoksevim
    Mustafa Doğduş
    Ahmet Kaya
    The International Journal of Cardiovascular Imaging, 2021, 37 : 165 - 173
  • [6] Effects of angiotensin receptor neprilysin inhibition on pulmonary arterial stiffness in heart failure with reduced ejection fraction
    Yenercag, Mustafa
    Arslan, Ugur
    Dereli, Seckin
    Coksevim, Metin
    Dogdus, Mustafa
    Kaya, Ahmet
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2021, 37 (01): : 165 - 173
  • [7] Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
    Mentz, Robert J.
    Ward, Jonathan H.
    Hernandez, Adrian F.
    Lepage, Serge
    Morrow, David A.
    Sarwat, Samiha
    Sharma, Kavita
    Starling, Randall C.
    Velazquez, Eric J.
    Williamson, Kristin M.
    Desai, Akshay S.
    Zieroth, Shelley
    Solomon, Scott D.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (01) : 1 - 12
  • [8] Efficacy of angiotensin-neprilysin inhibition versus enalapril in patient with heart failure with a reduced ejection fraction
    Ferrari, Laura
    Sada, Simona
    INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (03) : 369 - 371
  • [9] Heart Failure With Reduced Ejection Fraction A Review
    Murphy, Sean P.
    Ibrahim, Nasrien E.
    Januzzi, James L., Jr.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (05): : 488 - 504
  • [10] Soluble neprilysin predicts outcome in patients with heart failure with reduced ejection fraction
    Pavo, N.
    Wurm, R.
    Korn, S.
    Osorio, E.
    Huelsmann, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S325 - S325
12345